{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:18:50Z","timestamp":1789751930858,"version":"4.0.1"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.semcdb.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T10:59:45Z","timestamp":1607857185000},"page":"92-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Importance of lipids for upper motor neuron health and disease"],"prefix":"10.1016","volume":"112","author":[{"given":"Aksu","family":"Gunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather H.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oge","family":"Gozutok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Hande","family":"Ozdinler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"73","key":"10.1016\/j.semcdb.2020.11.004_bib1","article-title":"The electrophysiological determinants of corticospinal motor neuron vulnerability in ALS","volume":"13","author":"Jara","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn3469","article-title":"Corticostriatal connectivity and its role in disease","volume":"14","author":"Shepherd","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib3","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI71601","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ncl.2015.07.001","article-title":"Familial amyotrophic lateral sclerosis","volume":"33","author":"Boylan","year":"2015","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.semcdb.2020.11.004_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/brain\/awz382","article-title":"Lipid metabolic pathways converge in motor neuron degenerative diseases","volume":"143","author":"Rickman","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib6","doi-asserted-by":"crossref","first-page":"14732","DOI":"10.1038\/s41598-018-32902-4","article-title":"Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS","volume":"8","author":"Dervishi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2020.11.004_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","article-title":"Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration","volume":"102","author":"Branchu","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.semcdb.2020.11.004_bib8","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1091\/mbc.e13-03-0170","article-title":"Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15","volume":"24","author":"Hirst","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","article-title":"Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome","volume":"82","author":"Hanein","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2020.11.004_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fncel.2019.00212","article-title":"Lipid metabolism crosstalk in the brain: glia and neurons","volume":"13","author":"Barber","year":"2019","journal-title":"Front Cell Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2020.11.004_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jns.2015.05.031","article-title":"A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: a 30-year diagnostic delay caused by misleading biochemical findings","volume":"355","author":"Koutsis","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0034-1389161","article-title":"Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia","volume":"45","author":"Crow","year":"2014","journal-title":"Neuropediatrics"},{"issue":"Pt 8","key":"10.1016\/j.semcdb.2020.11.004_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/brain\/awv143","article-title":"Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia","volume":"138","author":"Coutelier","year":"2015","journal-title":"Brain"},{"issue":"Pt 1","key":"10.1016\/j.semcdb.2020.11.004_bib14","article-title":"ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism","volume":"139","author":"Panza","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/302681","article-title":"The molecular basis of Sjogren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene","volume":"65","author":"Rizzo","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1469-8749.2007.00152.x","article-title":"Sjogren-larsson syndrome","volume":"49","author":"Gordon","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"issue":"6170","key":"10.1016\/j.semcdb.2020.11.004_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.1247363","article-title":"Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders","volume":"343","author":"Novarino","year":"2014","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2020.11.004_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2011.03.011","article-title":"A new locus (SPG47) maps to 1p13.2-1p12 in an Arabic family with complicated autosomal recessive hereditary spastic paraplegia and thin corpus callosum","volume":"305","author":"Blumkin","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jmg.2010.082263","article-title":"Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability","volume":"48","author":"Moreno-De-Luca","year":"2011","journal-title":"J. Med Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2009.06.004","article-title":"Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy","volume":"85","author":"Verkerk","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"7367","key":"10.1016\/j.semcdb.2020.11.004_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature10423","article-title":"Deep sequencing reveals 50 novel genes for recessive cognitive disorders","volume":"478","author":"Najmabadi","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajhg.2011.04.019","article-title":"Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature","volume":"88","author":"Abou Jamra","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000408","article-title":"A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia","volume":"8","author":"Slabicki","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fnins.2020.00074","article-title":"Lipids in the physiopathology of hereditary spastic paraplegias","volume":"14","author":"Darios","year":"2020","journal-title":"Front Neurosci."},{"key":"10.1016\/j.semcdb.2020.11.004_bib25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","article-title":"Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms","volume":"261","author":"Lo Giudice","year":"2014","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/hmg\/ddx042","article-title":"ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia","volume":"26","author":"Cooper","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/ng758","article-title":"Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia","volume":"29","author":"Zhao","year":"2001","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajhg.2013.05.006","article-title":"Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia","volume":"93","author":"Boukhris","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2020.11.004_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28257","article-title":"The human cytoplasmic dynein interactome reveals novel activators of motility","volume":"6","author":"Redwine","year":"2017","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ajhg.2013.04.018","article-title":"Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia","volume":"92","author":"Oates","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome","volume":"36","author":"Windpassinger","year":"2004","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.semcdb.2020.11.004_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jmedgenet-2012-101212","article-title":"A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55)","volume":"49","author":"Shimazaki","year":"2012","journal-title":"J. Med. Genet."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/humu.22378","article-title":"Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12","volume":"34","author":"Landoure","year":"2013","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ajhg.2016.04.002","article-title":"Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia","volume":"98","author":"Gan-Or","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jmg.2005.039230","article-title":"Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia","volume":"43","author":"Bouhouche","year":"2006","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2014.4769","article-title":"Mutation in CPT1C associated with pure autosomal dominant spastic paraplegia","volume":"72","author":"Rinaldi","year":"2015","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajhg.2012.11.001","article-title":"Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia","volume":"91","author":"Tesson","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10545-017-0093-8","article-title":"Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)","volume":"40","author":"Salen","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000069920.42968.8D","article-title":"A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20416","article-title":"Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28)","volume":"57","author":"Bouslam","year":"2005","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib42","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajhg.2012.10.017","article-title":"Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia","volume":"91","author":"Schuurs-Hoeijmakers","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jmedgenet-2018-105711","article-title":"De novo mutation in ELOVL1 causes ichthyosis, acanthosis nigricans, hypomyelination, spastic paraplegia, high frequency deafness and optic atrophy","volume":"56","author":"Mueller","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcdb.2020.11.004_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41439-018-0036-4","article-title":"A new case of spastic paraplegia type 64 due to a missense mutation in the ENTPD1 gene","volume":"6","author":"Mamelona","year":"2019","journal-title":"Hum. Genome Var."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib45","first-page":"547","article-title":"A mutation of EPT1 (SELENOI) underlies a new disorder of Kennedy pathway phospholipid biosynthesis","volume":"140","author":"Ahmed","year":"2017","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.P081620","article-title":"EPT1 (selenoprotein I) is critical for the neural development and maintenance of plasmalogen in humans","volume":"59","author":"Horibata","year":"2018","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10048-011-0291-8","article-title":"A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18)","volume":"12","author":"Alazami","year":"2011","journal-title":"Neurogenetics"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib48","doi-asserted-by":"crossref","first-page":"E1251","DOI":"10.1002\/humu.21205","article-title":"Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35)","volume":"31","author":"Dick","year":"2010","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.22930","article-title":"Identified missense mutation in FARS2 causes autosomal-recessive spastic paraplegia","volume":"37","author":"Yang","year":"2016","journal-title":"Hum. Mutat."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2377-4-20","article-title":"Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-person syndrome and other movement disorders","volume":"4","author":"Lynex","year":"2004","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.11.021","article-title":"Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia","volume":"92","author":"Martin","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2020.11.004_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2020.03.019","article-title":"Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset","volume":"74","author":"Wassenberg","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"Pt 2","key":"10.1016\/j.semcdb.2020.11.004_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/brain\/awn328","article-title":"Hereditary spastic paraplegia is a novel phenotype for GJA12\/GJC2 mutations","volume":"132","author":"Orthmann-Murphy","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib54","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/ene.13194","article-title":"A new phenotype associated with homozygous GRN mutations: complicated spastic paraplegia","volume":"24","author":"Faber","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"23","key":"10.1016\/j.semcdb.2020.11.004_bib55","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M800548200","article-title":"The Hsp60-(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo","volume":"283","author":"Bross","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0000000000001270","article-title":"Fe\/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia","volume":"84","author":"Lossos","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.semcdb.2020.11.004_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41065-019-0104-x","article-title":"Hereditary spastic paraplegia associated with a rare IFIH1 mutation: a case report and literature review","volume":"156","author":"Liu","year":"2019","journal-title":"Hereditas"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib58","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ana.24762","article-title":"A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia","volume":"80","author":"Helbig","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/510782","article-title":"Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia","volume":"80","author":"Valdmanis","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib60","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1101\/gr.117143.110","article-title":"Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis","volume":"21","author":"Erlich","year":"2011","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jmedgenet-2013-102012","article-title":"KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction","volume":"51","author":"Dor","year":"2014","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib62","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.WNL.0000138731.60693.D2","article-title":"Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia","volume":"63","author":"Fichera","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib63","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ana.20478","article-title":"Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13","volume":"57","author":"Macedo-Souza","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/10.1.9","article-title":"The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein","volume":"10","author":"Blanco","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib65","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ng0794-402","article-title":"X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene","volume":"7","author":"Jouet","year":"1994","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib66","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/jnnp-2013-306981","article-title":"Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation","volume":"85","author":"Shimazaki","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib67","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4103\/1673-5374.248108","article-title":"Rescue axonal defects by targeting mitochondrial dynamics in hereditary spastic paraplegias","volume":"14","author":"Mou","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mito.2010.07.006","article-title":"Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation","volume":"11","author":"Verny","year":"2011","journal-title":"Mitochondrion"},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib69","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1468-1331.2011.03359.x","article-title":"NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy","volume":"18","author":"Svenstrup","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-012-0947-y","article-title":"TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1\/SPG6 mutation","volume":"124","author":"Martinez-Lage","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"Pt 3","key":"10.1016\/j.semcdb.2020.11.004_bib71","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.semcdb.2020.11.004_bib72","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00415-014-7481-x","article-title":"Costeff syndrome: clinical features and natural history","volume":"261","author":"Yahalom","year":"2014","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib73","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/cge.13008","article-title":"PLA2G6 mutations associated with a continuous clinical spectrum from neuroaxonal dystrophy to hereditary spastic paraplegia","volume":"92","author":"Ozes","year":"2017","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib74","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.46.4.1112","article-title":"Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia","volume":"46","author":"Cambi","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib75","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2007.12.018","article-title":"Neuropathy target esterase gene mutations cause motor neuron disease","volume":"82","author":"Rainier","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awx290","article-title":"POLR3A variants in hereditary spastic paraplegia and ataxia","volume":"141","author":"Gauquelin","year":"2018","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib77","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120103","article-title":"Evolution of signal multiplexing by 14-3-3-binding 2R-ohnologue protein families in the vertebrates","volume":"2","author":"Tinti","year":"2012","journal-title":"Open Biol."},{"issue":"Pt 4","key":"10.1016\/j.semcdb.2020.11.004_bib78","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/brain\/awn026","article-title":"REEP1 mutation spectrum and genotype\/phenotype correlation in hereditary spastic paraplegia type 31","volume":"131","author":"Beetz","year":"2008","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib79","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajhg.2013.12.005","article-title":"Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia","volume":"94","author":"Esteves","year":"2014","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib80","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2017.01.014","article-title":"Large intragenic deletion in DSTYK underlies autosomal-recessive complicated spastic paraparesis, SPG23","volume":"100","author":"Lee","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib81","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI60560","article-title":"Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12","volume":"122","author":"Montenegro","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jmedgenet-2017-104622","article-title":"SERAC1 deficiency causes complicated HSP: evidence from a novel splice mutation in a large family","volume":"55","author":"Roeben","year":"2018","journal-title":"J. Med. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-019-00565-6","article-title":"Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes","volume":"20","author":"Elert-Dobkowska","year":"2019","journal-title":"Neurogenetics"},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib84","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/humu.22331","article-title":"Relevance of different cellular models in determining the effects of mutations on SLC16A2\/MCT8 thyroid hormone transporter function and genotype-phenotype correlation","volume":"34","author":"Capri","year":"2013","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2020.11.004_bib85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ajmg.1320430173","article-title":"Allan-Herndon-Dudley syndrome: clinical and linkage studies on a second family","volume":"43","author":"Bialer","year":"1992","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ajhg.2008.11.003","article-title":"A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42)","volume":"83","author":"Lin","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ng937","article-title":"SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia","volume":"31","author":"Patel","year":"2002","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/hmg\/ddg004","article-title":"Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus","volume":"12","author":"Charvin","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib89","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/379522","article-title":"Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia","volume":"73","author":"Simpson","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib90","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000266667.91074.fe","article-title":"A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation","volume":"69","author":"Warnecke","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12144","article-title":"SPG11 mutations associated with a complex phenotype resembling dopa-responsive dystonia","volume":"2","author":"Wijemanne","year":"2015","journal-title":"Mov. Disord. Clin. Pr."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib92","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajhg.2012.09.015","article-title":"Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis","volume":"91","author":"Oz-Levi","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"13","key":"10.1016\/j.semcdb.2020.11.004_bib93","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1073\/pnas.1217197110","article-title":"Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure","volume":"110","author":"Beetz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib94","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nmd.2015.03.007","article-title":"Phenotypic variability of TRPV4 related neuropathies","volume":"25","author":"Evangelista","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"12","key":"10.1016\/j.semcdb.2020.11.004_bib95","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/humu.23602","article-title":"Motor protein binding and mitochondrial transport are altered by pathogenic TUBB4A variants","volume":"39","author":"Vulinovic","year":"2018","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib96","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1073\/pnas.1222732110","article-title":"Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration","volume":"110","author":"Bilguvar","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12929-017-0403-3","article-title":"The involvement of endoplasmic reticulum formation and protein synthesis efficiency in VCP- and ATL1-related neurological disorders","volume":"25","author":"Shih","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/jmedgenet-2012-100742","article-title":"A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis","volume":"49","author":"Zivony-Elboum","year":"2012","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib99","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.56.9.1230","article-title":"SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q","volume":"56","author":"Hughes","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/504927","article-title":"ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia","volume":"79","author":"Mannan","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/01.wnl.0000338530.77394.60","article-title":"A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family","volume":"72","author":"Mintchev","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib102","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ana.23641","article-title":"Loss of ERLIN2 function leads to juvenile primary lateral sclerosis","volume":"72","author":"Al-Saif","year":"2012","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.semcdb.2020.11.004_bib103","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/01.wnl.0000258678.58808.86","article-title":"Autosomal dominant primary lateral sclerosis","volume":"68","author":"Dupre","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib104","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000060","article-title":"Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis","volume":"2","author":"Yang","year":"2016","journal-title":"Neurol. Genet."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib105","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/humu.21542","article-title":"REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction","volume":"32","author":"Goizet","year":"2011","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib106","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mdc3.12184","article-title":"An update on the hereditary spastic paraplegias: new genes and new disease models","volume":"2","author":"Kumar","year":"2015","journal-title":"Mov. Disord. Clin. Pr."},{"issue":"Pt 1","key":"10.1016\/j.semcdb.2020.11.004_bib107","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1042\/BST0370208","article-title":"The role of CHMP2B in frontotemporal dementia","volume":"37","author":"Urwin","year":"2009","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.semcdb.2020.11.004_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104710","article-title":"Longitudinal transcriptomic analysis of altered pathways in a CHMP2B(intron5)-based model of ALS-FTD","volume":"136","author":"Waegaert","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib109","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/acs.biochem.7b01028","article-title":"Functional contribution of the spastic paraplegia-related triglyceride hydrolase DDHD2 to the formation and content of lipid droplets","volume":"57","author":"Inloes","year":"2018","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ejhg.2013.29","article-title":"Mutations in phospholipase DDHD2 cause autosomal recessive hereditary spastic paraplegia (SPG54)","volume":"21","author":"Gonzalez","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib111","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.semcdb.2020.11.004_bib112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fcell.2019.00210","article-title":"Monitoring the sphingolipid de novo synthesis by stable-isotope labeling and liquid chromatography-mass spectrometry","volume":"7","author":"Wigger","year":"2019","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib113","series-title":"Biochemistry","article-title":"The complex regulation of cholesterol biosynthesis takes place at several levels","author":"Berg","year":"2002"},{"key":"10.1016\/j.semcdb.2020.11.004_bib114","series-title":"Cholesterol","article-title":"Physiology","author":"Huff","year":"2020"},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bjorkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib116","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbamem.2011.06.014","article-title":"Side-chain oxysterols: from cells to membranes to molecules","volume":"1818","author":"Olsen","year":"2012","journal-title":"Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib117","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.bbrc.2013.11.059","article-title":"Effects of oxysterols on the blood-brain barrier: implications for Alzheimer\u2019s disease","volume":"446","author":"Gosselet","year":"2014","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"Pt 6","key":"10.1016\/j.semcdb.2020.11.004_bib118","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/brain\/awp073","article-title":"CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5","volume":"132","author":"Goizet","year":"2009","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib119","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1194\/jlr.M002543","article-title":"Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis","volume":"51","author":"Schule","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.semcdb.2020.11.004_bib120","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50 Suppl","author":"Bartke","year":"2009","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib121","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0421-18.2019","article-title":"Sphingomyelin in brain and cognitive development: preliminary data","volume":"6","author":"Schneider","year":"2019","journal-title":"eNeuro"},{"issue":"39","key":"10.1016\/j.semcdb.2020.11.004_bib122","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1523\/JNEUROSCI.0458-08.2008","article-title":"Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration","volume":"28","author":"Zoller","year":"2008","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib123","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/glia.21172","article-title":"Central nervous system dysfunction in a mouse model of FA2H deficiency","volume":"59","author":"Potter","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.semcdb.2020.11.004_bib124","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1476-511X-10-84","article-title":"2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase","volume":"10","author":"Dan","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm.2015.8","article-title":"Structure and function of ER membrane contact sites with other organelles","volume":"17","author":"Phillips","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib126","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1093\/cercor\/bhu318","article-title":"Corticospinal motor neurons are susceptible to increased er stress and display profound degeneration in the absence of UCHL1 function","volume":"25","author":"Jara","year":"2015","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-018-1934-8","article-title":"Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology","volume":"137","author":"Gautam","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib128","series-title":"Cell Biology","first-page":"331","article-title":"Endoplasmic reticulum","author":"Thomas","year":"2017"},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib129","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004713","article-title":"Synthesis and biosynthetic trafficking of membrane lipids","volume":"3","author":"Blom","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.devcel.2016.09.030","article-title":"Lipids and their trafficking: an integral part of cellular organization","volume":"39","author":"Jackson","year":"2016","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib131","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a013300","article-title":"Nonvesicular lipid transfer from the endoplasmic reticulum","volume":"4","author":"Lev","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib132","article-title":"Lipid synthesis and transport are coupled to regulate membrane lipid dynamics in the endoplasmic reticulum","volume":"1865","author":"Balla","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib133","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmet.2011.07.013","article-title":"Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP: phosphocholine cytidylyltransferase","volume":"14","author":"Krahmer","year":"2011","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib134","doi-asserted-by":"crossref","first-page":"R470","DOI":"10.1016\/j.cub.2015.04.004","article-title":"Expanding roles for lipid droplets","volume":"25","author":"Welte","year":"2015","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13353-016-0350-9","article-title":"Expression of genes involved in lipid droplet formation (BSCL2, SNAP23 and COPA) during porcine in vitro adipogenesis","volume":"57","author":"Kociucka","year":"2016","journal-title":"J. Appl. Genet."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib136","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2015.10.052","article-title":"An SOD1 deficiency enhances lipid droplet accumulation in the fasted mouse liver by aborting lipophagy","volume":"467","author":"Kurahashi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib137","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.devcel.2018.05.002","article-title":"Emerging links between lipid droplets and motor neuron diseases","volume":"45","author":"Pennetta","year":"2018","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib138","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.devcel.2013.01.013","article-title":"Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets","volume":"24","author":"Wilfling","year":"2013","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib139","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41387-018-0045-x","article-title":"Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance","volume":"8","author":"Yu","year":"2018","journal-title":"Nutr. Diabetes"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.celrep.2016.10.037","article-title":"SEIPIN regulates lipid droplet expansion and adipocyte development by modulating the activity of glycerol-3-phosphate acyltransferase","volume":"17","author":"Pagac","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib141","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1086\/321267","article-title":"The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype","volume":"69","author":"Patel","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib142","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-1809.1966.tb00007.x","article-title":"Familial spastic paraplegia with amyotrophy of the hands","volume":"30","author":"Silver","year":"1966","journal-title":"Ann. Hum. Genet."},{"issue":"5796","key":"10.1016\/j.semcdb.2020.11.004_bib143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.semcdb.2020.11.004_bib144","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","article-title":"Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation","volume":"283","author":"Winton","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/hmg\/ddu497","article-title":"Activation of AMP-activated protein kinase alpha1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis","volume":"24","author":"Liu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.semcdb.2020.11.004_bib146","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1038\/ncomms8176","article-title":"AMPK activation promotes lipid droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty acid oxidation","volume":"6","author":"Herms","year":"2015","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.semcdb.2020.11.004_bib147","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/ijms20163848","article-title":"Complexity of generating mouse models to study the upper motor neurons: let us shift focus from mice to neurons","volume":"20","author":"Genc","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.semcdb.2020.11.004_bib148","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1073\/pnas.172399499","article-title":"Appraising the brain\u2019s energy budget","volume":"99","author":"Raichle","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2020.11.004_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7821672","article-title":"What is \u201chyper\u201d in the ALS hypermetabolism?","volume":"2017","author":"Ferri","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17482960802295192","article-title":"High metabolic level in patients with familial amyotrophic lateral sclerosis","volume":"10","author":"Funalot","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"issue":"13","key":"10.1016\/j.semcdb.2020.11.004_bib151","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib152","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.410220504","article-title":"Lowered cerebral glucose utilization in amyotrophic lateral sclerosis","volume":"22","author":"Dalakas","year":"1987","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017985","article-title":"Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib154","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00004728-198807000-00019","article-title":"Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study","volume":"12","author":"Hatazawa","year":"1988","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib155","first-page":"306","article-title":"Brain FDG-PET changes in ALS and ALS-FTD","volume":"111","author":"Renard","year":"2011","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib156","doi-asserted-by":"crossref","first-page":"17652","DOI":"10.1038\/s41598-017-17389-9","article-title":"Lipidomics reveals cerebrospinal-fluid signatures of ALS","volume":"7","author":"Blasco","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.semcdb.2020.11.004_bib157","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482960902822960","article-title":"Impaired glucose tolerance in patients with amyotrophic lateral sclerosis","volume":"11","author":"Pradat","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib158","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","article-title":"Insulin resistance in amyotrophic lateral sclerosis","volume":"63","author":"Reyes","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.semcdb.2020.11.004_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110817","article-title":"Aging membranes: unexplored functions for lipids in the lifespan of the central nervous system","volume":"131","author":"Skowronska-Krawczyk","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0005-2736(96)00240-4","article-title":"Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane?","volume":"1325","author":"de Kroon","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib161","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-017-0022-7","article-title":"Disruption of ER\u2212mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis","volume":"9","author":"Lau","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib162","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrm3440","article-title":"Endoplasmic reticulum-mitochondria contacts: function of the junction","volume":"13","author":"Rowland","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib163","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"15","key":"10.1016\/j.semcdb.2020.11.004_bib164","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/MCB.00380-15","article-title":"Male-specific cardiac dysfunction in CTP: phosphoethanolamine cytidylyltransferase (Pcyt2)-deficient mice","volume":"35","author":"Basu","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fnmol.2018.00182","article-title":"Medium-chain fatty acids, beta-hydroxybutyric acid and genetic modulation of the carnitine shuttle are protective in a drosophila model of ALS based on TDP-43","volume":"11","author":"Manzo","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib166","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrendo.2015.129","article-title":"Acylcarnitines--old actors auditioning for new roles in metabolic physiology","volume":"11","author":"McCoin","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib167","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib168","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2017.06.003","article-title":"DGAT1-dependent lipid droplet biogenesis protects mitochondrial function during starvation-induced autophagy","volume":"42","author":"Nguyen","year":"2017","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib169","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1523\/JNEUROSCI.3829-04.2005","article-title":"Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice","volume":"25","author":"Kirkinezos","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib170","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","article-title":"Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis","volume":"9","author":"Chaves-Filho","year":"2019","journal-title":"Sci. Rep."},{"issue":"52","key":"10.1016\/j.semcdb.2020.11.004_bib171","doi-asserted-by":"crossref","first-page":"52873","DOI":"10.1074\/jbc.M308366200","article-title":"Cardiolipin stabilizes respiratory chain supercomplexes","volume":"278","author":"Pfeiffer","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib172","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbabio.2009.02.012","article-title":"Role of phospholipids in respiratory cytochrome bc(1) complex catalysis and supercomplex formation","volume":"1787","author":"Wenz","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib173","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1074\/jbc.M112.425876","article-title":"Cardiolipin-dependent reconstitution of respiratory supercomplexes from purified Saccharomyces cerevisiae complexes III and IV","volume":"288","author":"Bazan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib174","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-018-0815-3","article-title":"Loss of DDHD2, whose mutation causes spastic paraplegia, promotes reactive oxygen species generation and apoptosis","volume":"9","author":"Maruyama","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1523\/JNEUROSCI.3415-17.2018","article-title":"Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury","volume":"39","author":"Chao","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2020.11.004_bib176","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fncel.2019.00489","article-title":"Mitoautophagy: a unique self-destructive path mitochondria of upper motor neurons with TDP-43 pathology take, very early in ALS","volume":"13","author":"Gautam","year":"2019","journal-title":"Front Cell Neurosci."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib177","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001756-200303030-00038","article-title":"Investigation of mitochondrial function in hereditary spastic paraparesis","volume":"14","author":"McDermott","year":"2003","journal-title":"Neuroreport"},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib178","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","article-title":"An energy budget for signaling in the grey matter of the brain","volume":"21","author":"Attwell","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib179","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1523\/JNEUROSCI.3430-11.2012","article-title":"The energetics of CNS white matter","volume":"32","author":"Harris","year":"2012","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"40","key":"10.1016\/j.semcdb.2020.11.004_bib181","doi-asserted-by":"crossref","first-page":"16653","DOI":"10.1074\/jbc.M117.806786","article-title":"Ablating the protein TBC1D1 impairs contraction-induced sarcolemmal glucose transporter 4 redistribution but not insulin-mediated responses in rats","volume":"292","author":"Whitfield","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib182","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11910-018-0868-9","article-title":"Cerebral metabolic changes during sleep","volume":"18","author":"Aalling","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib183","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-018-4744-6","article-title":"Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes","volume":"62","author":"Weightman Potter","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.semcdb.2020.11.004_bib184","series-title":"Ketogenesis","article-title":"Biochemistry","author":"Dhillon","year":"2020"},{"issue":"4\u20135","key":"10.1016\/j.semcdb.2020.11.004_bib185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000094170","article-title":"Induction of monocarboxylate transporter 2 expression and ketone transport following traumatic brain injury in juvenile and adult rats","volume":"28","author":"Prins","year":"2006","journal-title":"Dev. Neurosci."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib186","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.20633","article-title":"Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury","volume":"82","author":"Prins","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib187","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2003.05.001","article-title":"Ketone body synthesis in the brain: possible neuroprotective effects","volume":"70","author":"Guzman","year":"2004","journal-title":"Prost. Leukot. Ess. Fat. Acids"},{"issue":"5","key":"10.1016\/j.semcdb.2020.11.004_bib188","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1096\/fj.201500182","article-title":"Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems","volume":"30","author":"Thevenet","year":"2016","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib189","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1471-4159.1991.tb11435.x","article-title":"Fatty acid oxidation and ketogenesis by astrocytes in primary culture","volume":"56","author":"Auestad","year":"1991","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib190","doi-asserted-by":"crossref","first-page":"R1186","DOI":"10.1152\/ajpregu.00113.2016","article-title":"Fatty acid-induced astrocyte ketone production and the control of food intake","volume":"310","author":"Le Foll","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib191","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim Biophys. Acta"},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib192","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","article-title":"Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain","volume":"33","author":"Schonfeld","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1646","key":"10.1016\/j.semcdb.2020.11.004_bib193","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0446","article-title":"How to deal with oxygen radicals stemming from mitochondrial fatty acid oxidation","volume":"369","author":"Speijer","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"12","key":"10.1016\/j.semcdb.2020.11.004_bib194","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cells7120274","article-title":"The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases","volume":"7","author":"Kausar","year":"2018","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcdb.2020.11.004_bib196","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.freeradbiomed.2013.06.029","article-title":"Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis","volume":"65","author":"D\u2019Amico","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib197","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib198","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/17482960801933942","article-title":"Oxidative stress biomarkers in sporadic ALS","volume":"9","author":"Mitsumoto","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.semcdb.2020.11.004_bib199","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnmol.2018.00015","article-title":"How can a ketogenic diet improve motor function?","volume":"11","author":"Veyrat-Durebex","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.semcdb.2020.11.004_bib200","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00008877-200609000-00009","article-title":"Neuroprotective and disease-modifying effects of the ketogenic diet","volume":"17","author":"Gasior","year":"2006","journal-title":"Behav. Pharm."},{"issue":"37","key":"10.1016\/j.semcdb.2020.11.004_bib201","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.2174\/1381612823666170809101517","article-title":"Ketogenic diets in the treatment of epilepsy","volume":"23","author":"Elia","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/nu12030788","article-title":"Modulation of cellular biochemistry, epigenetics and metabolomics by ketone bodies. implications of the ketogenic diet in the physiology of the organism and pathological states","volume":"12","author":"Dabek","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.semcdb.2020.11.004_bib203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.physbeh.2018.02.006","article-title":"A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder","volume":"188","author":"Lee","year":"2018","journal-title":"Physiol. Behav."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib204","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00431-016-2765-z","article-title":"The changing face of dietary therapy for epilepsy","volume":"175","author":"Pasca","year":"2016","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib205","doi-asserted-by":"crossref","DOI":"10.1542\/peds.105.4.e46","article-title":"Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy","volume":"105","author":"Lefevre","year":"2000","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib206","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11940-008-0043-8","article-title":"The ketogenic diet: uses in epilepsy and other neurologic illnesses","volume":"10","author":"Baranano","year":"2008","journal-title":"Curr. Treat. Options Neurol."},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib207","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1528-1167.2005.00282.x","article-title":"Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy","volume":"46","author":"Bergqvist","year":"2005","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.semcdb.2020.11.004_bib208","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.3390\/ijms21093266","article-title":"Aberrant mitochondrial morphology and function in the BTBR mouse model of autism is improved by two weeks of ketogenic diet","volume":"21","author":"Ahn","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcdb.2020.11.004_bib209","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.bbi.2020.05.032","article-title":"Anti-depression effects of ketogenic diet are mediated via the restoration of microglial activation and neuronal excitability in the lateral habenula","volume":"88","author":"Guan","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib210","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"Vanitallie","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-020-00615-4","article-title":"Are ketogenic diets promising for Alzheimer\u2019s disease? A translational review","volume":"12","author":"Lilamand","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib212","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13063-020-04273-7","article-title":"Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: study protocol for a randomized controlled trial","volume":"21","author":"Demirel","year":"2020","journal-title":"Trials"},{"issue":"30","key":"10.1016\/j.semcdb.2020.11.004_bib213","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.semcdb.2020.11.004_bib214","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2202-7-29","article-title":"A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis","volume":"7","author":"Zhao","year":"2006","journal-title":"BMC Neurosci."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-170660","article-title":"Lipid metabolism and survival across the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: relationships to eating behavior and cognition","volume":"61","author":"Ahmed","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib216","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00415-016-8168-2","article-title":"Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival","volume":"263","author":"Ahmed","year":"2016","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.semcdb.2020.11.004_bib217","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib218","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/eci.12591","article-title":"Ketogenic diets: from cancer to mitochondrial diseases and beyond","volume":"46","author":"Branco","year":"2016","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.semcdb.2020.11.004_bib219","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fpsyt.2019.00363","article-title":"Therapeutic potential of exogenous ketone supplement induced ketosis in the treatment of psychiatric disorders: review of current literature","volume":"10","author":"Kovacs","year":"2019","journal-title":"Front Psychiatry"},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049191","article-title":"Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.semcdb.2020.11.004_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103526","article-title":"Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model","volume":"9","author":"Ari","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib222","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2014.01.006","article-title":"A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer\u2019s disease","volume":"11","author":"Newport","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib223","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1194\/jlr.R067629","article-title":"Short- and medium-chain fatty acids in energy metabolism: the cellular perspective","volume":"57","author":"Schonfeld","year":"2016","journal-title":"J. Lipid Res"},{"issue":"11","key":"10.1016\/j.semcdb.2020.11.004_bib224","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/nu10111651","article-title":"Resveratrol, metabolic syndrome, and gut microbiota","volume":"10","author":"Chaplin","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.13466","article-title":"Resveratrol and cancer treatment: updates","volume":"1403","author":"Jiang","year":"2017","journal-title":"Ann. N.Y Acad. Sci."},{"issue":"38","key":"10.1016\/j.semcdb.2020.11.004_bib226","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.2174\/0929867324666170724102743","article-title":"Effects of resveratrol and other polyphenols on the most common brain age-related diseases","volume":"24","author":"Sarubbo","year":"2017","journal-title":"Curr. Med Chem."},{"issue":"34","key":"10.1016\/j.semcdb.2020.11.004_bib227","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Schutz","year":"2005","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib228","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037885","article-title":"A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis","volume":"7","author":"Dupuis","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.semcdb.2020.11.004_bib229","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2174\/1381612826666200212114038","article-title":"Potential therapeutic role of carnitine and acetylcarnitine in neurological disorders","volume":"26","author":"Maldonado","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcdb.2020.11.004_bib230","article-title":"Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy","volume":"6","author":"Rolim","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib231","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0304-3940(02)00667-5","article-title":"Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons","volume":"329","author":"Bigini","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.semcdb.2020.11.004_bib232","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neulet.2017.07.059","article-title":"Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor","volume":"658","author":"Kazak","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"5\u20136","key":"10.1016\/j.semcdb.2020.11.004_bib233","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/21678421.2013.764568","article-title":"Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS","volume":"14","author":"Beghi","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib234","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mus.20439","article-title":"Gene-based treatment of motor neuron diseases","volume":"33","author":"Federici","year":"2006","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib235","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00415-004-0322-6","article-title":"The future of motor neuron disease: the challenge is in the genes","volume":"251","author":"Veldink","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib236","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2019.00724","article-title":"Gene therapy tools for brain diseases","volume":"10","author":"Ingusci","year":"2019","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.semcdb.2020.11.004_bib237","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/gt.2015.112","article-title":"Healthy and diseased corticospinal motor neurons are selectively transduced upon direct AAV2-2 injection into the motor cortex","volume":"23","author":"Jara","year":"2016","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib238","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","article-title":"Hypermetabolism in ALS patients: an early and persistent phenomenon","volume":"256","author":"Bouteloup","year":"2009","journal-title":"J. Neurol."},{"issue":"5\u20136","key":"10.1016\/j.semcdb.2020.11.004_bib239","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/21678421.2015.1047454","article-title":"The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south-west China and a meta-analysis","volume":"16","author":"Huang","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.semcdb.2020.11.004_bib240","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fneur.2019.00284","article-title":"Lipid biomarkers for amyotrophic lateral sclerosis","volume":"10","author":"Gonzalez De Aguilar","year":"2019","journal-title":"Front Neurol."},{"issue":"4","key":"10.1016\/j.semcdb.2020.11.004_bib241","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.semcdb.2020.11.004_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/genes10121011","article-title":"Existing and emerging metabolomic tools for ALS research","author":"Germeys","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib243","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/CCLM.2008.006","article-title":"Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics","volume":"46","author":"Ala-Korpela","year":"2008","journal-title":"Clin. Chem. Lab Med."},{"issue":"6","key":"10.1016\/j.semcdb.2020.11.004_bib244","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14737159.7.6.761","article-title":"Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool","volume":"7","author":"Ala-Korpela","year":"2007","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"10","key":"10.1016\/j.semcdb.2020.11.004_bib245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013223","article-title":"1H NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis","volume":"5","author":"Blasco","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcdb.2020.11.004_bib246","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15280\/jlm.2014.4.1.17","article-title":"Mass spectrometry-based lipidomics and its application to biomedical research","volume":"4","author":"Wu","year":"2014","journal-title":"J. Lifestyle Med."},{"issue":"8","key":"10.1016\/j.semcdb.2020.11.004_bib247","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbalip.2015.02.007","article-title":"Measuring brain lipids","volume":"1851","author":"Dawson","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcdb.2020.11.004_bib248","first-page":"1","article-title":"Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis","author":"Bjornevik","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952120300045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952120300045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:03:25Z","timestamp":1761066205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952120300045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":248,"alternative-id":["S1084952120300045"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2020.11.004","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of lipids for upper motor neuron health and disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}